Literature DB >> 29330725

Cytologic Diagnosis of Biliary Strictures: FISH or Cut the Sensitivity Rate?

Douglas G Adler1, Benjamin Witt2.   

Abstract

Mesh：

Year:  2018        PMID： 29330725     DOI： 10.1007/s10620-017-4865-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

1.  Routine brush cytology and fluorescence in situ hybridization for assessment of pancreatobiliary strictures.

Authors:  Marian Smoczynski; Anna Jablonska; Anita Matyskiel; Joanna Lakomy; Michal Dubowik; Iwona Marek; Wojciech Biernat; Janusz Limon
Journal:  Gastrointest Endosc       Date:  2011-11-10       Impact factor: 9.427

2.  A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.

Authors:  Benjamin R Kipp; Linda M Stadheim; Shari A Halling; Nicole L Pochron; Scott Harmsen; David M Nagorney; Thomas J Sebo; Terry M Therneau; Gregory J Gores; Piet C de Groen; Todd H Baron; Michael J Levy; Kevin C Halling; Lewis R Roberts
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

3.  Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.

Authors:  Sarah E Kerr; Emily G Barr Fritcher; Michael B Campion; Jesse S Voss; Benjamin R Kipp; Kevin C Halling; Jason T Lewis
Journal:  Hum Pathol       Date:  2014-06-04       Impact factor: 3.466

4.  Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and UroVysion™ fluorescent in situ hybridization.

Authors:  Brent J Huddleston; Randy D Lamb; Evelyn V Gopez; Douglas G Adler; Brian T Collins
Journal:  Diagn Cytopathol       Date:  2011-02-13       Impact factor: 1.582

5.  A multistep cytological approach for patients with jaundice and biliary strictures of indeterminate origin.

Authors:  Renzo Boldorini; Alessia Paganotti; Silvano Andorno; Stefania Orlando; Francesca Mercalli; Marco Orsello; Marco Ballarè; Corrado Magnani; Massimo Sartori
Journal:  J Clin Pathol       Date:  2015-02-13       Impact factor: 3.411

6.  Immunological method for mapping genes on Drosophila polytene chromosomes.

Authors:  P R Langer-Safer; M Levine; D C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

7.  Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.

Authors:  Emily G Barr Fritcher; Jesse S Voss; Sarah M Jenkins; Ravi K Lingineni; Amy C Clayton; Lewis R Roberts; Kevin C Halling; Jayant A Talwalkar; Gregory J Gores; Benjamin R Kipp
Journal:  Cancer Cytopathol       Date:  2013-07-09       Impact factor: 5.284

8.  Role of Fluorescent In Situ Hybridization, Cholangioscopic Biopsies, and EUS-FNA in the Evaluation of Biliary Strictures.

Authors:  Christian Brooks; Valerie Gausman; Chanthel Kokoy-Mondragon; Khushboo Munot; Sunil P Amin; Amit Desai; Claudine Kipp; John Poneros; Amrita Sethi; Frank G Gress; Michel Kahaleh; Vundavalli V Murty; Reem Sharaiha; Tamas A Gonda
Journal:  Dig Dis Sci       Date:  2018-01-20       Impact factor: 3.199

9.  Cholangiocarcinoma and high-grade dysplasia in young patients with primary sclerosing cholangitis.

Authors:  Roy Liu; Kristen Cox; Stephen L Guthery; Linda Book; Benjamin Witt; Barbara Chadwick; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2014-04-19       Impact factor: 3.199
  9 in total
  2 in total

1.  Pancreatic ductal adenocarcinoma and distal cholangiocarcinoma: a proposal of preoperative diagnostic score for differential diagnosis.

Authors:  Edoardo Maria Muttillo; Antonio Ciardi; Raffaele Troiano; Paolina Saullo; Gabriele Masselli; Marianna Guida; Alessandra Tortora; Isabella Sperduti; Giulio Marinello; Piero Chirletti; Roberto Caronna
Journal:  World J Surg Oncol       Date:  2021-01-12       Impact factor: 2.754

2.  Refined pancreatobiliary UroVysion criteria and an approach for further optimization.

Authors:  Daniel Mettman; Azhar Saeed; Janna Shold; Raquele Laury; Andrew Ly; Irfan Khan; Shivani Golem; Mojtaba Olyaee; Maura O'Neil
Journal:  Cancer Med       Date:  2021-08-10       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.